Levofloxacina Galenica Senese

Levofloxacin, the active ingredient in Levofloxacina Galenica Senese, is a fluoroquinolone antibiotic presented as an injection solution for intravenous use. It treats a range of serious bacterial infections in adults and pediatric patients when oral therapy is unsuitable or ineffective.

GNH USA supplies Levofloxacina Galenica Senese as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other regulated markets. The product complies with EU pharmacopeial standards and is manufactured under strict quality‑assurance protocols.

Levofloxacin is indicated for several serious bacterial infections across different organ systems. - Community‑acquired pneumonia: achieves clinical cure and microbiological eradication in adult patients. - Complicated urinary tract infections: resolves infection and prevents recurrence in patients with structural or functional urinary abnormalities. - Skin and soft tissue infections: reduces lesion size and eliminates causative pathogens. - Intra‑abdominal infections: provides effective bacterial clearance after surgical or percutaneous source control. - Bacterial prostatitis: improves symptoms and eradicates the infecting organism in men with chronic prostatitis.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Rash

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to arrhythmia - Clostridioides difficile‑associated colitis - Severe allergic reactions such as anaphylaxis

Before initiating levofloxacin therapy, clinicians should consider several precautionary measures to minimize risk. - Renal function: adjust dosing in patients with impaired clearance. - Hepatic impairment: monitor liver enzymes and use with caution. - History of tendon disorders: avoid in patients with prior tendon injury or who are on corticosteroids. - Cardiac risk: assess QT interval and avoid in patients with known prolongation or electrolyte disturbances. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: increased risk of toxicity. - Antacids or supplements containing magnesium, aluminum, calcium, or iron: markedly reduce levofloxacin absorption. - Warfarin: may enhance anticoagulant effect and raise INR.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of central nervous system adverse events. - Systemic corticosteroids: increased likelihood of tendon injury. - Theophylline: potential for elevated plasma concentrations and toxicity.